Trial Profile
Study to investigate NLX-101 (F-15599) in patient with Rett syndrome.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 12 Jun 2015
Price :
$35
*
At a glance
- Drugs F 15599 (Primary)
- Indications Rett syndrome
- Focus Adverse reactions; Therapeutic Use
- Sponsors Neurolixis
- 12 Jun 2015 New trial record